0001217234-21-000206.txt : 20210817
0001217234-21-000206.hdr.sgml : 20210817
20210817185914
ACCESSION NUMBER: 0001217234-21-000206
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210625
FILED AS OF DATE: 20210817
DATE AS OF CHANGE: 20210817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seeto Reginald
CENTRAL INDEX KEY: 0001688485
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36536
FILM NUMBER: 211184530
MAIL ADDRESS:
STREET 1: C/O ARDELYX, INC.
STREET 2: 34175 ARDENWOOD BLVD, SUITE 200
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CareDx, Inc.
CENTRAL INDEX KEY: 0001217234
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 943316839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 TOWER PLACE
STREET 2: 9TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-287-2300
MAIL ADDRESS:
STREET 1: 1 TOWER PLACE
STREET 2: 9TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: XDx, Inc.
DATE OF NAME CHANGE: 20071010
FORMER COMPANY:
FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC
DATE OF NAME CHANGE: 20030203
4
1
wf-form4_162924113493011.xml
FORM 4
X0306
4
2021-06-25
0
0001217234
CareDx, Inc.
CDNA
0001688485
Seeto Reginald
C/O CAREDX, INC.
1 TOWER PLACE, 9TH FLOOR
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
See Remarks
Common Stock
2021-06-25
4
M
0
3247
24.35
A
135618
D
Common Stock
2021-06-25
4
M
0
5963
27.72
A
141581
D
Common Stock
2021-06-25
4
S
0
9210
95.1485
D
132371
D
Common Stock
2021-06-28
4
M
0
1545
24.35
A
133916
D
Common Stock
2021-06-28
4
M
0
11667
27.17
A
145583
D
Common Stock
2021-06-28
4
S
0
8522
95.4177
D
137061
D
Common Stock
2021-06-28
4
S
0
4690
96.3413
D
132371
D
Common Stock
2021-08-11
4
M
0
10821
27.72
A
143192
D
Employee Stock Option (right to buy)
24.35
2021-06-25
4
M
0
3247
0
D
2030-02-03
Common Stock
3247.0
31961
D
Employee Stock Option (right to buy)
27.72
2021-06-25
4
M
0
5963
0
D
2028-11-26
Common Stock
5963.0
66869
D
Employee Stock Option (right to buy)
24.35
2021-06-28
4
M
0
1545
0
D
2030-02-03
Common Stock
1545.0
30416
D
Employee Stock Option (right to buy)
27.17
2021-06-28
4
M
0
11667
0
D
2029-02-04
Common Stock
11667.0
14500
D
Employee Stock Option (right to buy)
27.72
2021-08-11
4
M
0
10821
0
D
2028-11-26
Common Stock
10821.0
56048
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $90.37, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $96.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.10 to $96.53, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter.
25% of the shares subject to the option vested on November 26, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
President & Chief Executive Officer
/s/ Reginald Seeto
2021-08-17